Children's hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310052, China
NCT Number: NCT07404722
The correction of ventral curvature in hypospadias follows a stepwise principle. Clinically, in some cases of hypospadias, residual severe ventral curvature (VC ≥ 30°) persists even after thorough skin degloving and transection of the urethral plate, due to the unbalanced development of the ventral and dorsal tunica albuginea of the corpus cavernosum. In such cases, ventral tunica albuginea incision and corporoplasty with a graft are mandatory.
Although the currently commonly used pedicled Tunica Vaginalis Flap (TVF) corporoplasty can effectively correct the curvature, it requires additional dissection of the scrotum and tunica vaginalis sac. This prolongs the operative time and poses risks of donor-site complications, such as testicular retraction and scrotal hematoma.
The novel Urethral Plate Flap (UPF) corporoplasty utilizes local pedicled urethral plate tissue for homologous repair. This study adopts a prospective, single-center, randomized, controlled, double-blind, non-inferiority trial design, enrolling 90 subjects. The aim is to verify that the therapeutic efficacy of the UPF technique in correcting such residual severe ventral curvature is non-inferior to that of TVF, while demonstrating significant advantages in surgical efficiency and donor-site safety.
This study aims, through a single-center, double-blind, RCT design, and under the strict indication of "residual severe ventral curvature after urethral plate transection," to verify efficacy via a "non-inferiority" hypothesis, and to verify safety and efficiency via a "superiority" hypothesis. The goal is to provide Level I evidence for the update of hypospadias guidelines, while simultaneously exploring the establishment of postoperative imaging evaluation standards.
Trial opening soon.
Get Notified6 month–14 year
Male
Interventional
Not applicable
Hangzhou, Zhejiang, 310052, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
① Glans diameter < 1 cm; ② Combined with cryptorchidism; ③ Combined with severe bleeding disorders or coagulation dysfunction.
1.After degloving and transecting the urethral plate, mobilize the urethral plate. 2.Transect the tunica albuginea at the point of maximal curvature to fully correct the ventral curvature. 3.Mobilize and open the tunica vaginalis sac, and harvest a pedicled Tunica Vaginalis Flap (TVF). 4.Transfer the TVF to the ventral side to repair the tunica albuginea defect, and suture with 6-0 absorbable sutures. 5.Mobilize the space between the scrotal skin and dartos fascia. Place 2 interrupted sutures between the external spermatic fascia near the testis and the dartos fascia at the scrotal base to fix the testis within the sub-dartos space.
1.After degloving and transecting the urethral plate, mobilize the urethral plate. 2.Transect the tunica albuginea at the point of maximal curvature to fully correct the ventral curvature. 3.Mobilize and open the tunica vaginalis sac, and harvest a pedicled Tunica Vaginalis Flap (TVF). 4.Transfer the TVF to the ventral side to repair the tunica albuginea defect, and suture with 6-0 absorbable sutures. 5.Mobilize the space between the scrotal skin and dartos fascia. Place 2 interrupted sutures between the external spermatic fascia near the testis and the dartos fascia at the scrotal base to fix the testis within the sub-dartos space.
Time frame: 12 Months Postoperatively
Recurrence of ventral curvature is defined as residual ventral curvature ≥ 10° on lateral photographs during artificial erection.
Time frame: Intraoperative
Recorded as the time from the "incision of the tunica albuginea" to the "completion of tunica albuginea repair and confirmation of a straight penis" (in minutes). This metric specifically excludes the time taken for urethroplasty and penile skin reconstruction to minimize confounding factors.
Time frame: From enrollment to the end of treatment at 12 months
Assessment of complications related to the graft harvest site, including:
Testicular events: Postoperative testicular retraction/ascent (defined as the testis position being higher than the middle of the scrotum).
Scrotal events: Scrotal hematoma, edema, and secondary infections caused by these conditions.
Time frame: 12 months postoperatively
Evaluation is performed by a sonographer blinded to group allocation using High-Frequency Penile Ultrasound Evaluation
Evaluation Parameters:
Continuity of the tunica albuginea (Categorized as: Continuous / Interrupted).
Time frame: 12 month postoperatively
Evaluation is performed by a sonographer blinded to group allocation using High-Frequency Penile Ultrasound Evaluation Evaluation Parameters: Echogenicity of the corpus cavernosum beneath the graft (Assessed for consistency with the host cavernous tissue)
Contact information is provided by the study sponsor or research team.
The Children's Hospital of Zhejiang University School of Medicine
Other
Urethral Plate Flap Versus Tunica Vaginalis Flap Corporoplasty for the Correction of Residual Severe Ventral Curvature After Urethral Plate Transection in Hypospadias Repair: A Single-Center, Randomized, Controlled, Non-Inferiority Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07240649
Acute COVID-19, Anastomosis, Leaking
View Trial DetailsNCT07197203
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
View Trial DetailsNCT03698721
Bladder Exstrophy, Bladder, Neurogenic
View Trial DetailsNCT07426731
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Istanbul, Turkey (Türkiye)
View Trial Details